Shares of Vera Therapeutics (VERA) sold off about 20% on Friday following news in competitor Otsuka’s 2024 earnings presentation that the ...
JPMorgan analyst Anupam Rama says Vera Therapeutics (VERA) shares closed down 20% on Friday, driven by Otsuka’s announcement that the biologics ...
Inc., a leading provider of identity and access management (IAM) solutions, finds itself at a critical juncture as it navigates a complex landscape of market opportunities and challenges. The ...
Q4 2024 Earnings Call Transcript February 13, 2025 CyberArk Software Ltd. beats earnings expectations. Reported EPS is $0.8, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback